You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《港股》恆指收跌0.9% 上半年累升兩成 老鋪黃金全日漲近15% 英皇系受壓
中國6月官方製造業PMI略勝預期,港股低開9點後反覆下跌,一度跌219點低見24,064點,並以近乎全日低位收市,收報24,072點,跌211點或0.87%。恆指全月累升3.4%,第二季累升4.1%,上半年累升兩成。國指跌84點或0.96%,收報8,678點,上半年累升約19%;恆生科技指數跌38點或0.72%,收報5,302點,上半年累升約18.7%。大市全日成交金額2,422.34億元。 車股方面,比亞迪(01211.HK)跌1.4%,公司擬叫停「價格戰」,或對購車政策作大調整。理想(02015.HK)下調第二季交付量展望至約10.8萬輛,股價收跌3.3%,為今日(30日)表現最差藍籌股。據報小米(01810.HK)YU7交貨時間最長56周出現黃牛炒作,小米逆市升1.7%。蔚來(09866.HK)升2.8%。小鵬(09868.HK)跌1.7%。電池股寧德時代(03750.HK)升0.7%。 科技股方面,阿里(09988.HK)跌2.1%,騰訊(00700.HK)跌1.9%。美團(03690.HK)跌3.2%。京東幣鏈科技澄清目前並無開始發行穩定幣,京東(09618.HK)跌1.8%。百度(09888.HK)及嗶哩嗶哩(09626.HK)各跌0.5%及升0.7%。網易(09999.HK)及快手(01024.HK)分別升1.5%與0.8%。此外,平安好醫生(01833.HK)及美圖(01357.HK)升2.5%及5.4%,騰訊音樂(01698.HK)、金軟(03888.HK)及心動(02400.HK)升0.5%至4.3%。晶片股中芯(00981.HK)及華虹(01347.HK)跌0.3%及0.7%。 醫藥股歌禮(01672.HK)美國專利遭石藥(01093.HK)向美國專利商標局提交複審,歌禮升5.2%,石藥跌0.4%。金斯瑞(01548.HK)收到禮新就抗PD-1單域抗體許可協議項下2.14億美元付款,股價升2.1%。藥明系藥明康德(02359.HK)及藥明生物(02269.HK)各升3.4%與2%。翰森製藥(03692.HK)升2.2%。 金融股方面,匯控(00005.HK)跌近0.1%。港交所(00388.HK)跌0.6%。友邦(01299.HK)跌1.7%。此外,信義光能(00968.HK)升4.2%,為表現最佳藍籌股。至於老鋪黃金(06181.HK)股價漲14.9%,該股禁售期剛屆滿。 英皇國際(00163.HK)披露債務違約,股價收跌11.8%。同系英皇資本(00717.HK)及英皇文化產業(00491.HK)亦跌18.2%與14.9%,英皇娛樂酒店(00296.HK)及英皇鐘錶珠寶(00887.HK)跌5.3%及8.3%。其他股份方面,香港中旅(00308.HK)反覆微升0.7%、冠城鐘錶(00256.HK)挫17.6%、國泰君安國際(01788.HK)則炒高13.6%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account